Disclosures for "A Rare MYH11 Gene Missense Variant in a Patient with Intracerebral Vascular and Ascending Aortic Disease and Clinical Strokes"
-
Dr. Petrea has nothing to disclose.
-
An immediate family member of Prof. Frank has received personal compensation for serving as an employee of Rheacell. An immediate family member of Prof. Frank has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Rheacell. An immediate family member of Prof. Frank has stock in Rheacell. Prof. Frank has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Olifir has nothing to disclose.
-
Dr. Siegel has nothing to disclose.
-
Dr. Huggins has nothing to disclose.
-
Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baim Institute for Clinical Research. Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific.